Penn Preclinical Study Outlines Cardiovascular Side Effects of Breast Cancer Drug
Perelman School of Medicine at the University of PennsylvaniaA receptor protein that is the target of the breast cancer drug trastuzumab (Herceptin) is needed for proper heart blood-vessel development, providing a better understanding of the cardiovascular side effects of trastuzumab commonly used for cancer.